A Phase IIB multicenter clinical trial of oral SAHA in advanced CTCL

(PI: Parker,Co-I: Chen) 1% effort 5 subjects

Awarded By

  • Merck

Contributors

Amount

  • $60,070.00

Start/End

  • October 2004 - December 2007